Jens Blobner

Munich, BY 81377, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Identification of prognostically relevant residual tumor in glioblastoma after surgery: A comparative analysis of MR-based RANO resect classes vs. [18F]FET PET.

Identification of prognostically relevant residual tumor in glioblastoma after surgery: A comparative analysis of MR-based RANO resect classes vs. [18F]FET PET.

Journal: Neuro-oncology

Published: March 18, 2026

Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3.

Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3.

Journal: Journal of neuro-oncology

Published: April 24, 2025

Determinants of long-term survival in patients with IDH-mutant gliomas.

Determinants of long-term survival in patients with IDH-mutant gliomas.

Journal: Journal of neuro-oncology

Published: July 16, 2024

Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.

Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 22, 2024

PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.

PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.

Journal: Cancer immunology, immunotherapy : CII

Published: May 21, 2024

Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution.

Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution.

Journal: Science advances

Published: October 27, 2023

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

Journal: Neuro-oncology advances

Published: June 08, 2023

Commentary: Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.

Commentary: Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.

Journal: Neurosurgery

Published: April 01, 2023

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer.

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer.

Journal: Oncoimmunology

Published: January 23, 2023

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection.

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection.

Journal: Acta neurochirurgica

Published: December 01, 2022

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.

Journal: Journal of neuro-oncology

Published: August 01, 2022

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model.

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model.

Journal: Frontiers in medicine

Published: July 13, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026